This case describes a posterior fossa mass due to blastomycotic infection in a non-immunocompromised 41-year-old male presenting with a chronic headache for over one year.Given the risk of herniation,no lumbar punctur...This case describes a posterior fossa mass due to blastomycotic infection in a non-immunocompromised 41-year-old male presenting with a chronic headache for over one year.Given the risk of herniation,no lumbar puncture could be performed.A full work-up found no evidence of systemic infection.Surgical resection helped identify the mass as a blastomycotic abscess.Magnetic resonance imaging characteristics of the mass were helpful in the identification of the mass as a fungal abscess.展开更多
Gliomas comprise the majority of malignant primary brain tumors in adults and remain a devastating diagnosis.^([1])Despite therapeutic advances,median survival in the radiation and temozolamide era for the most common...Gliomas comprise the majority of malignant primary brain tumors in adults and remain a devastating diagnosis.^([1])Despite therapeutic advances,median survival in the radiation and temozolamide era for the most common and most aggressive tumor type,glioblastoma(GBM),is 14-20 months and tumor recurrence is universal.^([2])A promising new direction to combat GBM is immunotherapy,which emerged from intensive research revealing that although highly immunogenic.展开更多
文摘This case describes a posterior fossa mass due to blastomycotic infection in a non-immunocompromised 41-year-old male presenting with a chronic headache for over one year.Given the risk of herniation,no lumbar puncture could be performed.A full work-up found no evidence of systemic infection.Surgical resection helped identify the mass as a blastomycotic abscess.Magnetic resonance imaging characteristics of the mass were helpful in the identification of the mass as a fungal abscess.
文摘Gliomas comprise the majority of malignant primary brain tumors in adults and remain a devastating diagnosis.^([1])Despite therapeutic advances,median survival in the radiation and temozolamide era for the most common and most aggressive tumor type,glioblastoma(GBM),is 14-20 months and tumor recurrence is universal.^([2])A promising new direction to combat GBM is immunotherapy,which emerged from intensive research revealing that although highly immunogenic.
